Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation

Reuters

05/06

Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation

Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-039783), on May 06, 2025, and is solely responsible for the information contained therein.

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

1
2
3
4
5
6
7
8
9
10

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/news/2533050755"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental"},"isCrawlerRequest":true,"__swrFallback__":{"@#url:\"https://stock-news.skytigris.cn/v3/news\",params:#id:\"2533050755\",edition:\"fundamental\",auth_exemption:1,,,undefined,":{"share":"https://ttm.financial/m/news/2533050755?lang=zh_TW&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2025-05-06 18:01","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2533050755","market":"us","top_or_hot":-1,"title":"Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation","media":"Reuters","content":"<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-039783), on May 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 12.5px; color: #7E829C; margin: 0;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nEmmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation\n</h2>\n<h4 class=\"meta\">\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1032215980\">\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time smaller\">2025-05-06 18:01</p>\n</div>\n</a>\n</h4>\n</header>\n<article>\n<html xmlns=\"http://www.w3.org/1999/xhtml\" xmlns:newsg2=\"http://iptc.org/std/nar/2006-10-01/\" xmlns:xhtml=\"http://www.w3.org/1999/xhtml\"><head><title>\n      Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation\n    </title></head><body><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<p>\n        Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.\n      </p>\n</div><div xmlns:xsd=\"http://www.w3.org/2001/XMLSchema\" xmlns:xsi=\"http://www.w3.org/2001/XMLSchema-instance\">\n<em>Disclaimer: <span>This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-039783), on May 06, 2025, and is solely responsible for the information contained therein.</span></em>\n</div></body></html>\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"EMMA","symbol_name":"Emmaus生命科學","start_time":0,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250506:nNDL2Xg9dg:1","article_id":"2533050755","we_media_id":"1032215980","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2533050755","pubTimestamp":1746525685,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1032215980","head_image":"https://community-static.tradeup.com/news/4567337cbdf294b657b1fa87c5488b48"},"summary":"Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"EMMA":"Emmaus生命科学","BK4123":"调查和咨询服务","LU2065732104.USD":"ALLSPRING (LUX) WF GLOBAL SMALL CAP EQUITY \"I\" (USD) ACC","CBZ":"CBIZ Inc","BK4007":"制药"},"translate_title":"Marcum辞职后，Emmaus Life Sciences Inc.任命CBIZ CPAs为新审计师","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"EMMA":0.9,"CBZ":0.9},"content_text":"Emmaus Life Sciences Inc. Appoints CBIZ CPAs as New Auditors Following Marcum's Resignation\n    \n\n        Emmaus Life Sciences Inc. announced a change in its certifying accountants following the acquisition of Marcum LLP's attest business by CBIZ CPAs P.C. As a result, Marcum resigned as the independent registered public accounting firm for Emmaus on May 2, 2025. The company's Audit Committee approved the engagement of CBIZ CPAs as the new independent registered public accounting firm. The audit report by Marcum for the fiscal year ended December 31, 2024, did not contain any adverse opinions or disagreements, but it did note substantial doubt about Emmaus's ability to continue as a going concern. Emmaus confirmed that no consultations regarding accounting principles or audit opinions were held with CBIZ CPAs prior to this engagement.\n      \n\nDisclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Emmaus Life Sciences Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-039783), on May 06, 2025, and is solely responsible for the information contained therein.","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"executive,event","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"}}}